The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung Cancer
Adam J. Schoenfeld(Memorial Sloan Kettering Cancer Center), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Joseph Montecalvo(Memorial Sloan Kettering Cancer Center), Yahya Daneshbod(Memorial Sloan Kettering Cancer Center), Matthew D. Hellmann(Memorial Sloan Kettering Cancer Center), Glenn Heller(Memorial Sloan Kettering Cancer Center), Chai Bandlamudi(Memorial Sloan Kettering Cancer Center), Mark T.A. Donoghue(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Barry S. Taylor(Memorial Sloan Kettering Cancer Center), Amanda Beras(Memorial Sloan Kettering Cancer Center), Jason C. Chang(Memorial Sloan Kettering Cancer Center), Jennifer L. Sauter(Memorial Sloan Kettering Cancer Center), Tyler Jacks(Howard Hughes Medical Institute), Natasha Rekhtman(Albert Einstein College of Medicine), Sonal Paul(NewYork–Presbyterian Brooklyn Methodist Hospital), Azadeh Namakydoust(Memorial Sloan Kettering Cancer Center), Jessica A. Lavery(Memorial Sloan Kettering Cancer Center), Hira Rizvi(Memorial Sloan Kettering Cancer Center), Carla P. Concepcion(Massachusetts Institute of Technology), Jacklynn V. Egger(Memorial Sloan Kettering Cancer Center)
Cited by 281
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k